Zhaoke Ophthalmology Limited, a leading ophthalmic pharmaceutical company dedicated to the research and development, manufacturing and commercialization of therapies that address significant unmet medical needs, is pleased to announce that the Company has entered into an exclusive license, supply and distribution agreement with Eyedetec Medical, Inc., a leading US-based company specializing in medical devices for the treatment of dry eye disease and meibomian gland dysfunction.
The ELM™ is not currently commercially available for sale in the U.S.